ORICIRO GENOMICS
OriCiro Genomics creates a better Bioeconomy with innovative genome technologies. The company creates a technology that covers "DNA assembly" and "circular DNA amplification", allowing to construct large circular DNA molecules without relying on conventional biological cloning.
ORICIRO GENOMICS
Industry:
Biotechnology Health Care Innovation Management Life Science
Founded:
2018-12-01
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.oriciro.com
Status:
Active
Email Addresses:
[email protected]
Total Funding:
12.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Domain Not Resolving Apache IPv6 JsDelivr Apple Mobile Web App Capable
Similar Organizations
Amwise Diagnostic
Amwise Diagnostic is a leader in precision medicine technology for cancer.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
hC Bioscience
hC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Werewolf Therapeutics
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Current Employees Featured
Founder
Investors List
UTEC - The University of Tokyo Edge Capital Partners
UTEC - The University of Tokyo Edge Capital Partners investment in Series B - OriCiro Genomics
Asahi Kasei
Asahi Kasei investment in Series B - OriCiro Genomics
ITOCHU Technology Ventures
ITOCHU Technology Ventures investment in Series B - OriCiro Genomics
Japan Finance
Japan Finance investment in Debt Financing - OriCiro Genomics
UTEC - The University of Tokyo Edge Capital Partners
UTEC - The University of Tokyo Edge Capital Partners investment in Series B - OriCiro Genomics
ITOCHU Technology Ventures
ITOCHU Technology Ventures investment in Series B - OriCiro Genomics
UTEC - The University of Tokyo Edge Capital Partners
UTEC - The University of Tokyo Edge Capital Partners investment in Series A - OriCiro Genomics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-07-20 | OriCiro Strengthens Leadership Team with Appointment of Shigemasa Sasaki as COO/CBO and Nasir Kato Bashiruddin as CTO |
Official Site Inspections
http://www.oriciro.com Semrush global rank: 2.43 M Semrush visits lastest month: 7.4 K
Unable to get host informations!!!
